A detailed history of Bank Of America Corp transactions in Zai Lab LTD stock. As of the latest transaction made, Bank Of America Corp holds 127,507 shares of ZLAB stock, worth $3.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,507
Previous 153,414 16.89%
Holding current value
$3.93 Million
Previous $2.46 Million 10.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$13.72 - $21.55 $355,444 - $558,295
-25,907 Reduced 16.89%
127,507 $2.21 Million
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $1.17 Million - $1.97 Million
73,416 Added 91.77%
153,414 $2.46 Million
Q4 2023

Feb 14, 2024

SELL
$22.97 - $30.58 $2.74 Million - $3.65 Million
-119,414 Reduced 59.88%
79,998 $2.19 Million
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $2.11 Million - $3.3 Million
-83,214 Reduced 29.44%
199,412 $5.53 Million
Q1 2023

May 12, 2023

BUY
$30.21 - $48.1 $3.03 Million - $4.83 Million
100,367 Added 55.07%
282,626 $9.4 Million
Q4 2022

Feb 10, 2023

SELL
$22.28 - $38.71 $683,305 - $1.19 Million
-30,669 Reduced 14.4%
182,259 $5.6 Million
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $7.48 Million - $11.3 Million
-218,824 Reduced 50.68%
212,928 $7.28 Million
Q2 2022

Aug 12, 2022

BUY
$23.14 - $49.68 $6.91 Million - $14.8 Million
298,789 Added 224.72%
431,752 $15 Million
Q1 2022

May 16, 2022

BUY
$27.77 - $64.4 $189,669 - $439,852
6,830 Added 5.41%
132,963 $5.85 Million
Q4 2021

Feb 08, 2022

SELL
$54.9 - $105.21 $1.18 Million - $2.27 Million
-21,535 Reduced 14.58%
126,133 $7.93 Million
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $896,385 - $1.52 Million
8,537 Added 6.14%
147,668 $15.6 Million
Q2 2021

Sep 13, 2021

BUY
$125.11 - $180.0 $17.4 Million - $25 Million
139,131 New
139,131 $24.6 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.